Vietnam Large Molecules Drug Substance CDMO Market (2025-2031) | Outlook, Revenue, Strategy, Consumer Insights, Strategic Insights, Demand, Competition, Drivers, Value, Growth, Segmentation, Restraints, Competitive, Industry, Pricing Analysis, Share, Forecast, Segments, Companies, Opportunities, Challenges, Size, Analysis, Supply, Trends, Investment Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Vietnam Country Macro Economic Indicators

3.2 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F

3.3 Vietnam Large Molecules Drug Substance CDMO Market - Industry Life Cycle

3.4 Vietnam Large Molecules Drug Substance CDMO Market - Porter's Five Forces

3.5 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F

3.6 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F

3.7 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Stage, 2021 & 2031F

3.8 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F

3.9 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for outsourcing in drug development and manufacturing due to cost-effectiveness and expertise offered by CDMOs.

4.2.2 Growth in the biopharmaceutical industry in Vietnam, leading to higher demand for large molecules drug substances and CDMO services.

4.2.3 Government initiatives and policies promoting the pharmaceutical industry and attracting foreign investments in Vietnam.

4.3 Market Restraints

4.3.1 Regulatory challenges and compliance requirements in the pharmaceutical industry affecting the operations of CDMOs.

4.3.2 Limited availability of skilled workforce and expertise in large molecules drug substance manufacturing.

4.3.3 Competition from established CDMOs in other countries posing a challenge for Vietnam's market penetration.

6.1 Vietnam Large Molecules Drug Substance CDMO Market, By Service Type

6.1.1 Overview and Analysis

6.1.2 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F

6.1.3 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021 - 2031F

6.1.4 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F

6.1.5 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Analytical Services, 2021 - 2031F

6.1.6 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Regulatory Support, 2021 - 2031F

6.1.7 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Packaging, 2021 - 2031F

6.2 Vietnam Large Molecules Drug Substance CDMO Market, By Molecule Type

6.2.1 Overview and Analysis

6.2.2 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F

6.2.3 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Recombinant Proteins, 2021 - 2031F

6.2.4 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Peptides, 2021 - 2031F

6.2.5 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Nucleic Acids, 2021 - 2031F

6.2.6 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Viral Vectors, 2021 - 2031F

6.3 Vietnam Large Molecules Drug Substance CDMO Market, By Stage

6.3.1 Overview and Analysis

6.3.2 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Preclinical, 2021 - 2031F

6.3.3 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021 - 2031F

6.3.4 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021 - 2031F

6.3.5 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Late-Stage, 2021 - 2031F

6.3.6 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Early-Stage, 2021 - 2031F

6.4 Vietnam Large Molecules Drug Substance CDMO Market, By Application

6.4.1 Overview and Analysis

6.4.2 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Oncology, 2021 - 2031F

6.4.3 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Immunology, 2021 - 2031F

6.4.4 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Neurology, 2021 - 2031F

6.4.5 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Rare Diseases, 2021 - 2031F

6.4.6 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F

6.5 Vietnam Large Molecules Drug Substance CDMO Market, By End User

6.5.1 Overview and Analysis

6.5.2 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F

6.5.3 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031F

6.5.4 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By Research Institutes, 2021 - 2031F

6.5.5 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By CROs, 2021 - 2031F

6.5.6 Vietnam Large Molecules Drug Substance CDMO Market Revenues & Volume, By CMOs, 2021 - 2031F

7.1 Vietnam Large Molecules Drug Substance CDMO Market Export to Major Countries

7.2 Vietnam Large Molecules Drug Substance CDMO Market Imports from Major Countries

8.1 Percentage of biopharmaceutical companies in Vietnam outsourcing drug substance manufacturing to CDMOs.

8.2 Number of new large molecules drug substances developed and manufactured in Vietnam.

8.3 Investment inflow in the Vietnamese CDMO market for large molecules drug substances.

9.1 Vietnam Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F

9.2 Vietnam Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Molecule Type, 2021 & 2031F

9.3 Vietnam Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Stage, 2021 & 2031F

9.4 Vietnam Large Molecules Drug Substance CDMO Market Opportunity Assessment, By Application, 2021 & 2031F

9.5 Vietnam Large Molecules Drug Substance CDMO Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 Vietnam Large Molecules Drug Substance CDMO Market Revenue Share, By Companies, 2024

10.2 Vietnam Large Molecules Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters